Prothena Biosciences Inc

Cytokinetics is a biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule drugs that specifically target the cytoskeleton. The company s focus on the cytoskeleton enables it to develop novel and potentially safer and more effective classes of drugs directed at treatments for cancer, cardiovascular disease and other diseases. The company has developed a cell biology driven approach and proprietary technologies to evaluate the function of many interacting proteins in the complex environment of the intact human cell. The approach has yielded novel small molecule drug candidates that are in clinical development and two novel small molecule potential drug candidates in development, one in cancer and the other for heart failure. Its most advanced drug candidate, ispinesib is the subject of a Phase II clinical trials program designed to evaluate its effectiveness in many different types of cancer. Cytokinetics is headquartered in South San Francisco.

Fluidigm Corporation is a leading biotechnology company based in South San Francisco, CA. They specialize in developing innovative technologies and instruments for life sciences research, with a focus on imaging mass cytometry, mass cytometry, and microfluidics. Their cutting-edge products and services cater to various areas of interest, including genomics, immune profiling, infectious disease analysis, and single-cell analysis. With a strong commitment to scientific excellence and customer satisfaction, Fluidigm Corporation is dedicated to advancing research and discovery in the field of biotechnology. Fluidigm Corporation offers a wide range of instruments, kits, reagents, and software solutions to support diverse research needs. Their advanced technologies, such as the CyTOF XT, Helios, and Hyperion Imaging Systems, enable high-throughput genomics, spatial biology analysis, and immune profiling. Additionally, they provide comprehensive services, including scientific consultation, training, and custom assay design. With a focus on innovation and collaboration, Fluidigm Corporation continues to be a trusted partner for researchers and scientists worldwide.Generated from the website

Portola Pharmaceuticals is a Bay Area–based pharmaceuticals company with a focus on bioresearch and drug development. Their efforts are directed towards global markets, specifically in the treatment of cardiovascular disease and inflammation. Generated from their available business information